Position in ELAN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$968,944
+$96,576 QoQ
Shares Held
39,372
+8.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#230
of 518 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $32,206,115 across 15 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
783,835 | $12,564,875 | |
| 2 | HLN |
Haleon plc
|
749,194 | $6,989,980 | |
| 3 | ZTS |
Zoetis Inc.
|
63,238 | $4,544,282 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,957 | $1,602,191 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,701 | $1,466,466 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
39,372 | $968,944 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
84,915 | $913,685 | |
| 8 | ALKS |
Alkermes plc.
|
12,517 | $655,828 |
All Filings in ELAN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $968,944 | 39,372 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $872,368 | 36,455 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $218,967 | 9,676 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||